Biosecurity Modernization and Innovation Act of 2026 aims to enhance biosecurity and biosafety oversight by the federal government.
The Biosecurity Modernization and Innovation Act of 2026 mandates the Director of the Office of Science and Technology Policy to assess the current state of biosecurity and biosafety oversight by the federal government and develop an implementation plan to improve it. The Secretary of Commerce is required to establish regulations for nucleic acid synthesis security, including screening protocols for covered providers and a list of sequences of concern.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.